Unknown

Dataset Information

0

Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion.


ABSTRACT: Angiogenesis is increasingly recognized as an important prognosticator associated with the progression of lymphoma and as an attractive target for novel modalities. We report a previously unrecognized mechanism by which lymphoma endothelium facilitates the growth and dissemination of lymphoma by interacting with circulated T cells and suppresses the activation of CD4(+) T cells. Global gene expression profiles of microdissected endothelium from lymphoma and reactive lymph nodes revealed that T cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) was preferentially expressed in lymphoma-derived endothelial cells (ECs). Clinically, the level of Tim-3 in B cell lymphoma endothelium was closely correlated to both dissemination and poor prognosis. In vitro, Tim-3(+) ECs modulated T cell response to lymphoma surrogate antigens by suppressing activation of CD4(+) T lymphocytes through the activation of the interleukin-6-STAT3 pathway, inhibiting Th1 polarization, and providing protective immunity. In a lymphoma mouse model, Tim-3-expressing ECs promoted the onset, growth, and dissemination of lymphoma by inhibiting activation of CD4(+) T cells and Th1 polarization. Our findings strongly argue that the lymphoma endothelium is not only a vessel system but also a functional barrier facilitating the establishment of lymphoma immune tolerance. These findings highlight a novel molecular mechanism that is a potential target for enhancing the efficacy of tumor immunotherapy and controlling metastatic diseases.

SUBMITTER: Huang X 

PROVIDER: S-EPMC2839144 | biostudies-literature | 2010 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion.

Huang Xiaoyuan X   Bai Xiangyang X   Cao Yang Y   Wu Jingyi J   Huang Mei M   Tang Duozhuang D   Tao Si S   Zhu Tao T   Liu Yanling Y   Yang Yang Y   Zhou Xiaoxi X   Zhao Yanxia Y   Wu Mingfu M   Wei Juncheng J   Wang Daowen D   Xu Gang G   Wang Shixuan S   Ma Ding D   Zhou Jianfeng J  

The Journal of experimental medicine 20100222 3


Angiogenesis is increasingly recognized as an important prognosticator associated with the progression of lymphoma and as an attractive target for novel modalities. We report a previously unrecognized mechanism by which lymphoma endothelium facilitates the growth and dissemination of lymphoma by interacting with circulated T cells and suppresses the activation of CD4(+) T cells. Global gene expression profiles of microdissected endothelium from lymphoma and reactive lymph nodes revealed that T c  ...[more]

Similar Datasets

| S-EPMC7067145 | biostudies-literature
| S-EPMC11357674 | biostudies-literature
| S-EPMC10653885 | biostudies-literature
| S-EPMC7600905 | biostudies-literature
| S-EPMC6225903 | biostudies-literature
| S-EPMC9542094 | biostudies-literature
| S-EPMC6889000 | biostudies-literature
| S-EPMC9600505 | biostudies-literature
| S-EPMC8445817 | biostudies-literature
| S-EPMC6957316 | biostudies-literature